Tuesday, February 9, 2010
  • Font size
  • Bookmark
  • Save
Featured ContentAcceptance: Stages of Grief, Part III

Timing, type of HRT may determine breast cancer risk

(HealthScout) UPDATED 2009-09-21
The timing and type of hormone replacement therapy menopausal women receive appears to determine their risk for breast cancer, a new study has found. Researchers found that women who started estrogen-progestagen HRT in the two years after menopause had a 54 percent increased risk of breast cancer when compared with women who didn't take HRT. But women who took estrogen-progesterone HRT did not appear to have the increased risk.  Read full story >
See all Breast Cancer News
  • Font size
  • Bookmark
  • Was this helpful? Yes
  • Save

People who read this also read...